tradingkey.logo

Haemonetics Corp

HAE
查看详细走势图
79.910USD
-0.100-0.12%
交易中 美东报价延迟15分钟
3.74B总市值
23.28市盈率 TTM

Haemonetics Corp

79.910
-0.100-0.12%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-0.12%

5天

+0.01%

1月

-0.89%

6月

+8.87%

今年开始到现在

+2.34%

1年

+3.23%

查看详细走势图

TradingKey Haemonetics Corp股票评分

单位: USD 更新时间: 2025-12-24

操作建议

Haemonetics Corp当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名26/206位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价85.91。中期看,股价处于上升通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Haemonetics Corp评分

相关信息

行业排名
26 / 206
全市场排名
96 / 4562
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 11 位分析师
买入
评级
85.909
目标均价
+3.24%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Haemonetics Corp亮点

亮点风险
Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
业绩高增长
公司营业收入稳步增长,连续3年增长16.44%
利润高增长
公司净利润处于行业前列,最新年度总收入1.36B美元
估值低估
公司最新PE估值23.30,处于3年历史低位
机构减仓
最新机构持股54.60M股,环比减少8.66%
乔尔·格林布拉特持仓
明星投资者乔尔·格林布拉特持仓,最新持仓市值22.93K
活跃度增加
近期活跃度增加,过去20天平均换手率1.27

Haemonetics Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Haemonetics Corp简介

Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
公司代码HAE
公司Haemonetics Corp
CEOSimon (Christopher A)
网址https://www.haemonetics.com

常见问题

Haemonetics Corp(HAE)的当前股价是多少?

Haemonetics Corp(HAE)的当前股价是 79.910。

Haemonetics Corp的股票代码是什么?

Haemonetics Corp的股票代码是HAE。

Haemonetics Corp股票的52周最高点是多少?

Haemonetics Corp股票的52周最高点是87.320。

Haemonetics Corp股票的52周最低点是多少?

Haemonetics Corp股票的52周最低点是47.315。

Haemonetics Corp的市值是多少?

Haemonetics Corp的市值是3.74B。

Haemonetics Corp的净利润是多少?

Haemonetics Corp的净利润为167.68M。

现在Haemonetics Corp(HAE)的股票是买入、持有还是卖出?

根据分析师评级,Haemonetics Corp(HAE)的总体评级为买入,目标价格为85.909。

Haemonetics Corp(HAE)股票的每股收益(EPS TTM)是多少

Haemonetics Corp(HAE)股票的每股收益(EPS TTM)是3.433。
KeyAI